An effective anticonvulsant prepared following a host-guest strategy that uses hydroxypropyl-β-cyclodextrin and benzaldehyde semicarbazone

被引:36
作者
Beraldo, H [1 ]
Sinisterra, RD
Teixeira, LR
Vieira, RP
Doretto, MC
机构
[1] Univ Fed Minas Gerais, Dept Quim, BR-31270901 Belo Horizonte, MG, Brazil
[2] Univ Fed Minas Gerais, Dept Fisiol & Biofis, BR-31270901 Belo Horizonte, MG, Brazil
关键词
anticonvulsants; semicarbazones; cyclodextrins; pharmaceutical formulations; bio-availability;
D O I
10.1016/S0006-291X(02)00865-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The convulsions of approximately 25% of epileptics are inadequately controlled by currently available medication; therefore the preparation of new antiepileptic drugs is of great interest. Aryl semicarbazones can be considered a new class of compounds presenting anticonvulsant activity. In addition, they can be orally administered and are more active as anticonvulsants than mephenytoin or phenobarbital. However, one disadvantage of these compounds is their low water solubility, As a strategy to circumvent this problem, a 1:1 inclusion compound of benzaldehyde semicarbazone (BS) and hydroxypropyl-beta-cyclodextrin (HP-beta-CD) was prepared and characterized. The anticonvulsant activities of the free semicarbazone and of the inclusion compound were evaluated in rats using the maximum electroshock and audiogenic seizures screenings. In both tests the minimum dose of compound necessary to produce activity decreases from 100 mg/kg for the free semicarbazone to 35 mg/kg for the inclusion compound, indicating a significant increase in the bio-availability of the drug. (C) 2002 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:241 / 246
页数:6
相关论文
共 19 条
[1]   Growth and characterisation of benzaldehyde semicarbazone (BSC) single crystals [J].
Ramesh Babu, R. ;
Vijayan, N. ;
Gopalakrishnan, R. ;
Ramasamy, P. .
2002, Elsevier (240) :3-4
[2]   Spectral studies of semicarbazones derived from 3-and 4-formylpyridine and 3-and 4-acetylpyridine: crystal and molecular structure of 3-formylpyridine semicarbazone [J].
Beraldo, H ;
Nacif, WF ;
West, DX .
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2001, 57 (09) :1847-1854
[3]  
CORTES ME, 2001, J INCLUSION PHENOM, P1
[4]  
Dimmock J. R., 1998, Semicarbazones having CNS activity and pharmaceutical preparations containing same, Patent No. [U.S. Pat. 5, 741, 818, 5741818]
[5]   ANTICONVULSANT ACTIVITIES OF SOME ARYLSEMICARBAZONES DISPLAYING POTENT ORAL ACTIVITY IN THE MAXIMAL ELECTROSHOCK SCREEN IN RATS ACCOMPANIED BY HIGH PROTECTION INDEXES [J].
DIMMOCK, JR ;
SIDHU, KK ;
THAYER, RS ;
MACK, P ;
DUFFY, MJ ;
REID, RS ;
QUAIL, JW ;
PUGAZHENTHI, U ;
ONG, A ;
BIKKER, JA ;
WEAVER, DF .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (16) :2243-2252
[6]  
DIMMOCK JR, 1994, Patent No. 9406758
[7]  
DORETTO MC, 2000, ANN 1 LAT C EP SANT
[8]  
Garcia-Cairasco N, 1990, EPILEPSIA, V31, P815
[9]   Neuroethological and morphological (Neo-Timm staining) correlates of limbic recruitment during the development of audiogenic kindling in seizure susceptible Wistar rats [J].
GarciaCairasco, N ;
Wakamatsu, H ;
Oliveira, JAC ;
Gomes, ELT ;
DelBel, EA ;
Mello, LEAM .
EPILEPSY RESEARCH, 1996, 26 (01) :177-192
[10]   Cyclodextrin-based controlled drug release system [J].
Hirayama, F ;
Uekama, K .
ADVANCED DRUG DELIVERY REVIEWS, 1999, 36 (01) :125-141